Overview

Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma

Status:
Withdrawn
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Phase 2 single-institution trial of early systemic central nervous system prophylaxis in high-risk diffuse large B-cell lymphoma
Phase:
Phase 2
Details
Lead Sponsor:
Brown University
Treatments:
Cytarabine
Methotrexate